Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Ohtuvayre™ (ensifentrine) – New drug approval

June 26, 2024 - Verona Pharma announced the FDA approval of Ohtuvayre (ensifentrine), for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.

Download PDF

Rx navigation